Cancer Research and Treatment

Cancer Research and Treatment Search

> Browse Articles > Search

Gastrointestinal cancer

A Single-Arm Phase II Study of Nab-Paclitaxel Plus Gemcitabine and Cisplatin for Locally Advanced or Metastatic Biliary Tract Cancer

Ting Liu, Qing Li, Zhen Lin, Chunhua Liu, Wei Pu, Shasha Zeng, Jun Lai, Xuebin Cai, Lisha Zhang, Shuyang Wang, Miao Chen, Wei Cao, Hongfeng Gou, Qing Zhu

Cancer Res Treat. 2024;56(2):602-615. Published online October 12, 2023 DOI: https://doi.org/10.4143/crt.2023.726

Crossref 1

Gemcitabine Inhibits the Progression of Pancreatic Cancer by Restraining the WTAP/MYC Chain in an m6A-Dependent Manner

Pei Cao, Weigang Zhang, Junyi Qiu, Zuxiong Tang, Xiaofeng Xue, Tingting Feng

Cancer Res Treat. 2024;56(1):259-271. Published online August 16, 2023 DOI: https://doi.org/10.4143/crt.2022.1600

Web of Science 2 Crossref 1

Gynecologic cancer

Effectiveness of Concomitant Chemoradiotherapy with Gemcitabine in Locally Advanced Cervical Cancer Patients with Comorbidities

Hasan Brau-Figueroa, Eder Arango-Bravo, Denisse Castro-Eguiluz, Tatiana Galicia-Carmona, Leopoldo Abraham Lugo-Alferez, Ivette Cruz-Bautista, Roberto Jiménez-Lima, Lucely Cetina-Pérez

Cancer Res Treat. 2022;54(2):554-562. Published online August 10, 2021 DOI: https://doi.org/10.4143/crt.2021.375

Web of Science 1 Crossref 1

Genitourinary Cancer

Use of Gemcitabine plus Carboplatin is Associated with Poor Outcomes in Urothelial Carcinoma Patients with Chronic Kidney Disease Stage 4-5

Hyung-Don Kim, Hyeon-Su Im, Jwa Hoon Kim, Hyehyun Jeong, Shin Kyo Yoon, Inkeun Park, Jae Lyun Lee

Cancer Res Treat. 2021;53(4):1166-1173. Published online March 4, 2021 DOI: https://doi.org/10.4143/crt.2021.091

Web of Science 2 Crossref 2

Gastrointestinal Cancer

Phase II Trial of Postoperative Adjuvant Gemcitabine and Cisplatin Chemotherapy Followed by Chemoradiotherapy with Gemcitabine in Patients with Resected Pancreatic Cancer

Kyung-Hun Lee, Eui Kyu Chie, Seock-Ah Im, Jee Hyun Kim, Jihyun Kwon, Sae-Won Han, Do-Youn Oh, Jin-Young Jang, Jae-Sung Kim, Tae-You Kim, Yung-Jue Bang, Sun Whe Kim, Sung W. Ha

Cancer Res Treat. 2021;53(4):1096-1103. Published online December 30, 2020 DOI: https://doi.org/10.4143/crt.2020.928

Crossref 9

Gastrointestinal cancer

Effect of Combining EGFR Tyrosine Kinase Inhibitors and Cytotoxic Agents on Cholangiocarcinoma Cells

Boonyakorn Boonsri, Kiren Yacqub-Usman, Pakpoom Thintharua, Kyaw Zwar Myint, Thannicha Sae-Lao, Pam Collier, Chinnawut Suriyonplengsaeng, Noppadol Larbcharoensub, Brinda Balasubramanian, Simran Venkatraman, Isioma U. Egbuniwe, Dhanwant Gomez, Abhik Mukherjee, Supeecha Kumkate, Tavan Janvilisri, Abed M Zaitoun, Thiti Kuakpaetoon, Rutaiwan Tohtong, Anna M Grabowska, David O. Bates, Kanokpan Wongprasert

Cancer Res Treat. 2021;53(2):457-470. Published online October 7, 2020 DOI: https://doi.org/10.4143/crt.2020.585

Crossref 7

Clinical Outcomes of Second-Line Chemotherapy after Progression on Nab-Paclitaxel Plus Gemcitabine in Patients with Metastatic Pancreatic Adenocarcinoma

Kyoungmin Lee, Kyunghye Bang, Changhoon Yoo, Inhwan Hwang, Jae Ho Jeong, Heung-Moon Chang, Dongwook Oh, Tae Jun Song, Do Hyun Park, Sang Soo Lee, Sung Koo Lee, Myung-Hwan Kim, Jin-hong Park, Kyu-pyo Kim, Baek-Yeol Ryoo

Cancer Res Treat. 2020;52(1):254-262. Published online July 9, 2019 DOI: https://doi.org/10.4143/crt.2019.190

Web of Science 10 Crossref 12

Clinical Benefit of Maintenance Therapy for Advanced Biliary Tract Cancer Patients Showing No Progression after First-Line Gemcitabine Plus Cisplatin

Jaewon Hyung, Bumjun Kim, Changhoon Yoo, Kyo-pyo Kim, Jae Ho Jeong, Heung-Moon Chang, Baek-Yeol Ryoo

Cancer Res Treat. 2019;51(3):901-909. Published online October 4, 2018 DOI: https://doi.org/10.4143/crt.2018.326

Web of Science 15 Crossref 16

Gemcitabine and Docetaxel Combination for Advanced Soft Tissue Sarcoma: A Nationwide Retrospective Study

Yunjung Choi, Mi Sun Yun, Sang Hee Lim, Jeeyun Lee, Jin-Hee Ahn, Yu Jung Kim, Kyong Hwa Park, Young Suk Park, Ho Yeong Lim, Hyonggin An, Dong-Churl Suh, Yeul Hong Kim

Cancer Res Treat. 2018;50(1):175-182. Published online March 30, 2017 DOI: https://doi.org/10.4143/crt.2016.535

Web of Science 15 Crossref 18

Induction Chemotherapy with Gemcitabine and Cisplatin Followed by Simultaneous Integrated Boost–Intensity Modulated Radiotherapy with Concurrent Gemcitabine for Locally Advanced Unresectable Pancreatic Cancer: Results from a Feasibility Study

Sang Myung Woo, Min Kyeong Kim, Jungnam Joo, Kyong-Ah Yoon, Boram Park, Sang-Jae Park, Sung-Sik Han, Ju Hee Lee, Eun Kyung Hong, Yun-Hee Kim, Hae Moon, Sun-Young Kong, Tae Hyun Kim, Woo Jin Lee

Cancer Res Treat. 2017;49(4):1022-1032. Published online January 19, 2017 DOI: https://doi.org/10.4143/crt.2016.495

Web of Science 9 Crossref 9

Efficacy and Safety of First-Line Necitumumab Plus Gemcitabine and Cisplatin Versus Gemcitabine and Cisplatin in East Asian Patients with Stage IV Squamous Non-small Cell Lung Cancer: A Subgroup Analysis of the Phase 3, Open-Label, Randomized SQUIRE Study

Keunchil Park, Eun Kyung Cho, Maximino Bello, Myung-Ju Ahn, Sumitra Thongprasert, Eun-Kee Song, Victoria Soldatenkova, Henrik Depenbrock, Tarun Puri, Mauro Orlando

Cancer Res Treat. 2017;49(4):937-946. Published online January 6, 2017 DOI: https://doi.org/10.4143/crt.2016.423

Web of Science 8 Crossref 5

Prognostic Factors for Risk Stratification of Patients with Recurrent or Metastatic Pancreatic Adenocarcinoma Who Were Treated with Gemcitabine-Based Chemotherapy

Inkeun Park, Seung Joon Choi, Young Saing Kim, Hee Kyung Ahn, Junshik Hong, Sun Jin Sym, Jinny Park, Eun Kyung Cho, Jae Hoon Lee, Yong Ju Shin, Dong Bok Shin

Cancer Res Treat. 2016;48(4):1264-1273. Published online March 23, 2016 DOI: https://doi.org/10.4143/crt.2015.250

Web of Science 39 Crossref 39

A Phase II Study of Weekly Paclitaxel Plus Gemcitabine as a Second-Line Therapy in Patients with Metastatic or Recurrent Small Cell Lung Cancer

Tak Yun, Heung Tae Kim, Ji-Youn Han, Sung Jin Yoon, Hyae Young Kim, Byung-Ho Nam, Jin Soo Lee

Cancer Res Treat. 2016;48(2):465-472. Published online May 26, 2015 DOI: https://doi.org/10.4143/crt.2015.061

Web of Science 11 Crossref 12

p21-Activated Kinase 4 (PAK4) as a Predictive Marker of Gemcitabine Sensitivity in Pancreatic Cancer Cell Lines

Sung-Ung Moon, Jin Won Kim, Ji Hea Sung, Mi Hyun Kang, Se-Hyun Kim, Hyun Chang, Jeong-Ok Lee, Yu Jung Kim, Keun-Wook Lee, Jee Hyun Kim, Soo-Mee Bang, Jong Seok Lee

Cancer Res Treat. 2015;47(3):501-508. Published online November 24, 2014 DOI: https://doi.org/10.4143/crt.2014.054

Web of Science 33 Crossref 24

Gemcitabine Plus Cisplatin for Advanced Biliary Tract Cancer: A Systematic Review

Joon Oh Park, Do-Youn Oh, Chiun Hsu, Jen-Shi Chen, Li-Tzong Chen, Mauro Orlando, Jong Seok Kim, Ho Yeong Lim

Cancer Res Treat. 2015;47(3):343-361. Published online May 18, 2015 DOI: https://doi.org/10.4143/crt.2014.308

Web of Science 68 Crossref 64

Gemcitabine Combined with Capecitabine Compared to Gemcitabine with or without Erlotinib as First-Line Chemotherapy in Patients with Advanced Pancreatic Cancer

Jae Yun Lim, Jang Ho Cho, Se Joon Lee, Dong Ki Lee, Dong Sup Yoon, Jae Yong Cho

Cancer Res Treat. 2015;47(2):266-273. Published online August 29, 2014 DOI: https://doi.org/10.4143/crt.2013.158

Web of Science 13 Crossref 6

Comparison of the Efficacy between Gemcitabine-Cisplatin and Capecitabine-Cisplatin Combination Chemotherapy for Advanced Biliary Tract Cancer

Jieun Lee, Tae Ho Hong, In Seok Lee, Young Kyoung You, Myung Ah Lee

Cancer Res Treat. 2015;47(2):259-265. Published online September 12, 2014 DOI: https://doi.org/10.4143/crt.2013.230

Web of Science 11 Crossref 11

A Phase II Trial of Gemcitabine plus Capecitabine for Patients with Advanced Pancreatic Cancer

Jong Gwon Choi, Jae Hong Seo, Sang Cheul Oh, Chul Won Choi, Jun Suk Kim

Cancer Res Treat. 2012;44(2):127-132. Published online June 30, 2012 DOI: https://doi.org/10.4143/crt.2012.44.2.127

Crossref 9

Weekly Gemcitabine and Docetaxel in Refractory Soft Tissue Sarcoma: A Retrospective Analysis

Ha-young Lee, Sang Joon Shin, Hyo Song Kim, Soo Jung Hong, Jung Woo Han, Seung Taek Lim, Jae Kyung Roh, Sun Young Rha

Cancer Res Treat. 2012;44(1):43-49. Published online March 31, 2012 DOI: https://doi.org/10.4143/crt.2012.44.1.43

Crossref 13

Gemcitabine Plus Platinum Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Retrospective Analysis

Sang Hoon Chun, Ji Eun Lee, Mi Hee Park, Jin-Hyoung Kang, Young Kyoon Kim, Young-Pil Wang, Jae Kil Park, Hoon-Kyo Kim

Cancer Res Treat. 2011;43(4):217-224. Published online December 27, 2011 DOI: https://doi.org/10.4143/crt.2011.43.4.217

Crossref 5

A Case of Gemcitabine and Cisplatin Associated Posterior Reversible Encephalopathy Syndrome

Eun Jin Kwon, Se Won Kim, Kwang Ki Kim, Hyung Suk Seo, Do Yeun Kim

Cancer Res Treat. 2009;41(1):53-55. Published online March 31, 2009 DOI: https://doi.org/10.4143/crt.2009.41.1.53

Crossref 24

Gemcitabine and Carboplatin Combination Chemotherapy for Elderly Patients with Advanced Non-small Cell Lung Cancer: A Feasibility Study

Young Jin Yuh, Hyo Rak Lee, Sung Rok Kim

Cancer Res Treat. 2008;40(3):116-120. Published online September 30, 2008 DOI: https://doi.org/10.4143/crt.2008.40.3.116

Crossref 8

Phase II Study of Gemcitabine plus Cisplatin in Patients with Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer

Jung Hwan Kim, Sung Yong Oh, Hyuk-Chan Kwon, Suee Lee, Sung-Hyun Kim, Dae-Cheol Kim, Jin-Hwa Lee, Hyung-Sik Lee, Se-Heun Cho, Hyo-Jin Kim

Cancer Res Treat. 2008;40(3):101-105. Published online September 30, 2008 DOI: https://doi.org/10.4143/crt.2008.40.3.101

Crossref 8

Gemcitabine and Vinorelbine Combination Chemotherapy in Anthracycline- and Taxane-pretreated Advanced Breast Cancer

Hye Jin Kim, Jin-Soo Kim, Myung-Deok Seo, So-Yeon Oh, Do-Youn Oh, Jee Hyun Kim, Se-Hoon Lee, Dong-Wan Kim, Seock-Ah Im, Tae-You Kim, Dae Seog Heo, Yung-Jue Bang

Cancer Res Treat. 2008;40(2):81-86. Published online June 30, 2008 DOI: https://doi.org/10.4143/crt.2008.40.2.81

Crossref 5

Gemcitabine versus Gemcitabine Combined with Cisplatin Treatment Locally Advanced or Metastatic Pancreatic Cancer: A Retrospective Analysis

Jae-Hyuk Choi, Sung Yong Oh, Hyuk-Chan Kwon, Jung Hwan Kim, Jae Hoon Lee, Suee Lee, Dong Mee Lee, Sung-Hyun Kim, Myung Hwan Rho, Young-Hoon Kim, Mee-Sook Rho, Hyo-Jin Kim

Cancer Res Treat. 2008;40(1):22-26. Published online March 31, 2008 DOI: https://doi.org/10.4143/crt.2008.40.1.22

Crossref 9

Gemcitabine Single or Combination Chemotherapy in Post Anthracycline and Taxane Salvage Treatment of Metastatic Breast Cancer: Retrospective Analysis of 124 Patients

Min Kyoung Kim, Sung-Bae Kim, Jin Hee Ahn, Soon Im Lee, Sei-Hyun Ahn, Byung Ho Son, Gyungyub Gong, Hak-Hee Kim, Jung-Shin Lee, Yoon-Koo Kang, Woo Kun Kim

Cancer Res Treat. 2006;38(4):206-213. Published online December 31, 2006 DOI: https://doi.org/10.4143/crt.2006.38.4.206

Crossref 1

Efficacy of Combined Gemcitabine/Cisplatin Chemotherapy for Locally Advanced or Metastatic Urothelial Cancer

Kwan-Sik Bae, Kyu Il Ahn, Seung Hyun Jeon, Jung-Sik Huh, Sung-Goo Chang

Cancer Res Treat. 2006;38(2):78-83. Published online April 30, 2006 DOI: https://doi.org/10.4143/crt.2006.38.2.78

Crossref 1

Combination of Gemcitabine and Cisplatin as First-Line Therapy in Advanced Non-Small-Cell Lung Cancer

Nam-Su Lee, Jae-Ho Byun, Sang-Byung Bae, Chan-Kyu Kim, Kyu-Taeg Lee, Sung-Kyu Park, Jong-Ho Won, Dae-Sik Hong, Hee-Sook Park

Cancer Res Treat. 2004;36(3):173-177. Published online June 30, 2004 DOI: https://doi.org/10.4143/crt.2004.36.3.173

Crossref 7

A 21-day Schedule of Gemcitabine and Cisplatin Administration in the Treatment of Advanced Non-Small Cell Lung Carcinoma: a Phase II Study

Jong-Sung Park, Chang-Min Lee, Shin-Ae Lee, Chang-kil Jung, Sung-Hyun Kim, Hyuk-Chan Kwon, Jae-Seok Kim, Hyo-Jin Kim

Cancer Res Treat. 2004;36(1):62-67. Published online February 29, 2004 DOI: https://doi.org/10.4143/crt.2004.36.1.62

Phase II Study of Gemcitabine and Vinorelbine as Second-Line Chemotherapy in Non-Small Cell Lung Cancer

Yoon Jae Kim, Joo Hyuk Sohn, Chul Kim, Yong Tai Kim, Hai Jin Kim, Joong Bae Ahn, Se Kyu Kim, Joon Chang, Nae Choon Yoo, Joo Hang Kim, Jae Yong Cho

Cancer Res Treat. 2003;35(4):294-298. Published online August 31, 2003 DOI: https://doi.org/10.4143/crt.2003.35.4.294